Participation to Colorectal Cancer Screening With Fecal Occult Blood Test and Colonoscopy

Istituto Superiore di Sanità9,889 enrolled

Overview

Adherence rate to screening colonoscopy (TC) in the average-risk general population is still unclear. Aim of this study was to compare the uptake of TC screening with that of fecal occult blood (FOBT) in the general population of different Italian areas.

A nationwide, population-based, multicenter, randomized trial comparing attendance to TC with that to FOBT was performed. Sixty-four general practitioners (GPs), overall including in their lists 9,889 average-risk subjects aged 55-64 years, were randomized between TC and FOBT screening programs. Eligible subjects were mailed a personal invitation letter co-signed by their GP and the coordinator of the area-reference GI centre. Attendance rate and detection rate for advanced neoplasia (colorectal cancer, adenoma \>10 mm or with villous histology or high-grade dysplasia) for each arm of the study were assessed.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

9,889

Conditions

Colorectal Cancer

Interventions

colonoscopyPROCEDURE

colonoscopy screening

faecal testPROCEDURE

faecal occult blood test for screening

Eligibility

Sex: ALLMin age: 55 YearsMax age: 64 Years

Medical Language ↔ Plain English

Inclusion Criteria: * asymptomatic 55-64 years subjects Exclusion Criteria: * already studied for colorectal cancer, severe comorbidities

Locations (1)

IIstituto Nazionale Tumori Regina Elena

Rome, Italy

Outcomes

Primary Outcomes

Participation to colorectal cancer screening

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.